UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma

被引：0

作者：

Zhan Wang

Xiaoyan Liu

Xiang Liu

Haidan Sun

Zhengguang Guo

Guoyang Zheng

Yushi Zhang

Wei Sun

机构：

[1] Peking Union Medical College Hospital,Department of Urology

[2] Chinese Academy of Medical Sciences,Core facility of instrument

[3] Peking Union Medical College,undefined

[4] Institute of Basic Medical Sciences,undefined

[5] Chinese Academy of Medical Sciences,undefined

[6] School of Basic Medicine,undefined

[7] Peking Union Medical College,undefined

来源：

BMC Cancer | / 19卷

关键词：

Metabolomics; UPLC-MS; Biomarkers; Bladder cancer; Renal cell carcinoma;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 46 条

[21] A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico Verification
Hu, Leihao
He, Canfeng
Mo, Aier
Zhan, Xingkai
Yang, Caizhi
Guo, Wei
Sun, Lingling
Su, Weiwei
Lin, Lizhu
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2023, 2023
[22] MRI-based radiomics machine learning model to differentiate non-clear cell renal cell carcinoma from benign renal tumors
Wang, Ruiting
Zhong, Lianting
Zhu, Pingyi
Pan, Xianpan
Chen, Lei
Zhou, Jianjun
Ding, Yuqin
EUROPEAN JOURNAL OF RADIOLOGY OPEN, 2024, 13
[23] LC-MS/MS-Based Metabolomic Profiling of Constituents from Glochidion velutinum and Its Activity against Cancer Cell Lines
Shah, Syed Luqman
Bashir, Kashif
Rasheed, Hafiz Majid
Rahman, Jamil Ur
Ikram, Muhammad
Shah, Abdul Jabbar
Majrashi, Kamlah Ali
Alnasser, Sulaiman Mohammed
Menaa, Farid
Khan, Taous
MOLECULES, 2022, 27 (24):
[24] Telomerase activities in bladder tissues, bladder washes and in urine from patients with transitional cell carcinoma: A rapid and non-invasive technique to identify bladder cancer.
Bhuiyan, J
Roberts, SG
Thibodeau, SN
OKane, DJ
CLINICAL CHEMISTRY, 1997, 43 : 532 - 532
[25] MRI-Based Radiomics and Urine Creatinine for the Differentiation of Renal Angiomyolipoma With Minimal Fat From Renal Cell Carcinoma: A Preliminary Study
Jian, Lian
Liu, Yan
Xie, Yu
Jiang, Shusuan
Ye, Mingji
Lin, Huashan
FRONTIERS IN ONCOLOGY, 2022, 12
[26] GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients
Monteiro, Marcia
Moreira, Nathalie
Pinto, Joana
Pires-Luis, Ana S.
Henrique, Rui
Jeronimo, Carmen
Bastos, Maria de Lourdes
Gil, Ana M.
Carvalho, Marcia
de Pinho, Paula Guedes
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (09) : 2092 - 2105
[27] Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles
Gruetzmann, Konrad
Salomo, Karsten
Krueger, Alexander
Lohse-Fischer, Andrea
Erdmann, Kati
Seifert, Michael
Baretton, Gustavo
Aust, Daniela
William, Doreen
Schroeck, Evelin
Thomas, Christian
Fuessel, Susanne
BIOLOGY DIRECT, 2024, 19 (01)
[28] Using tree analysis pattern and SELDI-TOF-MS to discriminate transitional cell carcinoma of the bladder cancer from noncancer patients
Liu, WW
Guan, M
Wu, DL
Zhang, YF
Wu, Z
Xu, M
Lu, Y
EUROPEAN UROLOGY, 2005, 47 (04) : 456 - 462
[29] Adaptive genetic algorithms combined with high sensitivity single cell-based technology derived urine-based score to differentiate between high-grade and low-grade transitional cell carcinoma of the bladder
Alanee, Shaheen Riadh
Roumayah, Zade
Deebajah, Musatafa
Peabody, James O.
Mora, Rodrigo
Guevara, Jose
Francisco, Brian
Patterson, Bruce Kendrick
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[30] A CT-Based Tumoral and Mini-Peritumoral Radiomics Approach: Differentiate Fat-Poor Angiomyolipoma from Clear Cell Renal Cell Carcinoma
Ma, Yanqing
Xu, Xiren
Pang, Peipei
Wen, Yang
CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1417 - 1425

← 1 2 3 4 5 →